ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세포 치료 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 168억 7,000만 달러에서 2026년에는 193억 1,000만 달러로, CAGR 14.5%로 성장할 것으로 예상됩니다. 지금까지의 성장 요인으로는 자가 세포 치료의 높은 비용, 공여자의 공급 제한, 제조 공정의 표준화 부족, 초기 단계의 성공적인 임상시험, 만성질환의 증가 등을 꼽을 수 있습니다.
세포 치료 시장 규모는 향후 몇 년간 급속한 성장할 것으로 예상됩니다. 2030년에는 324억 8,000만 달러에 달하고, CAGR은 13.9%를 기록할 전망입니다. 예측 기간의 성장 요인으로는 유전자 편집 기술의 발전, 세포 제조 자동화, 세포 치료 스타트업에 대한 투자 확대, 재생의료 수요 증가, 종양학 및 심혈관질환(CVD) 분야에서의 응용 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 맞춤형 세포 치료의 개발, 동종 이식 치료의 발전, 세포 보존 및 수송 기술의 향상, 규제 및 규정 준수 혁신, 새로운 임상 응용 분야의 출현 등이 있습니다.
만성질환의 유병률 증가가 세포 치료 시장의 성장을 뒷받침하고 있습니다. 미국 질병예방통제센터(CDC)에 따르면, 만성질환은 1년 이상 지속되고, 의료적 처치가 필요하거나 일상 생활에 제한을 주거나 둘 다에 해당하는 상태를 말하며, 심장병, 암, 당뇨병, 파킨슨병 등이 이에 해당합니다. 줄기세포는 척수 손상, 1형 당뇨병, 파킨슨병, 심장병, 암, 골관절염 환자들에게 잠재적인 이점을 제공할 수 있습니다. 예를 들어, 2024년 7월 CDC가 발표한 공중보건정책에 대한 중요한 업데이트에 따르면, 심장병이나 뇌졸중으로 인한 사망자가 연간 94만 4,800명을 넘어 전체 사망자의 3분의 1 이상을 차지할 것으로 보고되었습니다. 암은 연간 170만 명이 새로 진단받고 60만 명 이상이 사망하며, 사망원인 2위를 차지하고 있습니다. 당뇨병 환자는 3,800만 명 이상, 전당뇨병 상태의 성인은 9,800만 명 이상에 달합니다. 또한, 비만은 어린이의 20%, 성인의 42%에 영향을 미치며, 제2형 당뇨병, 심장병, 특정 암의 위험을 증가시킵니다. 이러한 만성질환의 증가 추세는 세포 치료 수요를 견인하며 시장 확대에 기여하고 있습니다.
세포 치료 시장의 주요 기업들은 치료 성과 향상과 복잡한 암의 미충족 수요에 대응하기 위해 강력한 초기 임상 데이터를 바탕으로 차세대 다표적 치료제를 개발하고 있습니다. 예를 들어, 2025년 6월 미국 제약사 존슨앤드존슨은 재발성 또는 난치성 대세포성 B세포 림프종에 대한 이중 표적 CAR-T 세포 치료 'JNJ-4496'의 임상 Ib상 시험에서 유망한 초기 결과를 보고했습니다. 2025년 유럽혈액학회(EHA)에서 발표된 초기 데이터에 따르면, 권장 2상 용량에서 75-80%의 완전 반응률을 보였으며, 3-4등급 사이토카인 방출 증후군은 발생하지 않았습니다. 이번 치료는 유망한 안전성, 관리 가능한 신경독성, 다제내성 환자에서도 강력한 활성을 보여줌으로써 차세대 이중표적 CAR-T 치료의 가능성을 다시 한 번 강조하고, 존슨앤드존슨의 B세포 악성종양에 대한 혁신적 치료법 개발 의지를 다시 한 번 확인시켜 주었습니다. 다시 한 번 강조하는 계기가 되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Cell therapy involves the replacement or repair of damaged tissues and/or cells through the transplantation of human cells. Various types of cells can be employed in treatments for numerous diseases and disorders, supported by advanced technologies, innovative products, and creative approaches. In this therapy, patients receive live cells through injection, grafting, or implantation to achieve a therapeutic effect.
The primary techniques in cell therapy include stem cell therapy, cell vaccines, adoptive cell transfer (ACT), fibroblast cell therapy, and chondrocyte cell therapy. Stem cell therapy, also called regenerative medicine, utilizes stem cells or their derivatives to trigger the healing of diseased, damaged, or injured tissues. Different therapy types include allogeneic and autologous therapies, which are applied in various fields such as oncology, cardiovascular disease (CVD), orthopedics, wound healing, and more.
Tariffs have introduced both challenges and opportunities for the cell therapy market by affecting the import and export of human cells, reagents, and specialized manufacturing equipment. Increased costs for critical raw materials and delays in supply chains have particularly impacted segments like stem cell therapy and CAR T-cell therapy, with North America and Europe experiencing the most disruption due to reliance on imported biologics. Some companies are leveraging tariffs to localize production and invest in domestic cell manufacturing facilities, potentially improving resilience and innovation in the long term.
The cell therapy market research report is one of a series of new reports from The Business Research Company that provides cell therapy market statistics, including cell therapy industry global market size, regional shares, competitors with a cell therapy market share, detailed cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy industry. This cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cell therapy market size has grown rapidly in recent years. It will grow from $16.87 billion in 2025 to $19.31 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to high cost of autologous therapies, limited donor availability, lack of standardized manufacturing, early-stage clinical trial success, rising incidence of chronic diseases.
The cell therapy market size is expected to see rapid growth in the next few years. It will grow to $32.48 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in gene editing, automation in cell manufacturing, growing investment in cell therapy startups, increasing demand for regenerative medicine, expanding application across oncology and cvd. Major trends in the forecast period include personalized cell therapy development, allogeneic therapy advancements, improved cell storage & transportation, regulatory & compliance innovations, emerging clinical applications.
The rising prevalence of chronic diseases has supported the growth of the cell therapy market. According to the US Centers for Disease Control and Prevention (CDC), a chronic disease is a condition lasting one year or more that requires medical attention, limits daily activities, or both, and includes heart disease, cancer, diabetes, and Parkinson's disease. Stem cells offer potential benefits for patients with spinal cord injuries, type 1 diabetes, Parkinson's disease, heart disease, cancer, and osteoarthritis. For example, in July 2024, the CDC reported significant updates on public health initiatives: over 944,800 Americans die annually from heart disease or stroke, representing more than one-third of all deaths; 1.7 million are diagnosed with cancer each year, with over 600,000 fatalities, making it the second leading cause of death; more than 38 million Americans have diabetes, with 98 million adults prediabetic; and obesity affects 20% of children and 42% of adults, increasing the risk of type 2 diabetes, heart disease, and certain cancers. This growing prevalence of chronic diseases has driven demand for cell therapies, contributing to market expansion.
Key players in the cell therapy market are developing next-generation, multi-targeted therapies backed by strong early-stage clinical data to improve treatment outcomes and address unmet needs in complex cancers. For instance, in June 2025, Johnson & Johnson, a US-based pharmaceutical company, reported promising initial results from its Phase 1b study of JNJ-4496, a dual-targeting CAR T-cell therapy designed to bind both CD19 and CD20 in relapsed or refractory large B-cell lymphoma. Early data presented at the 2025 EHA Congress showed 75-80% complete responses at the recommended Phase 2 dose, with no Grade 3-4 cytokine release syndrome. The therapy demonstrated encouraging safety, manageable neurotoxicity, and robust activity even in heavily pretreated patients, highlighting the potential of next-generation dual-targeting CAR T therapies and reinforcing Johnson & Johnson's commitment to advancing innovative treatments for B-cell malignancies.
In August 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Sigilon Therapeutics for $34.6 million. This acquisition allows Lilly to strengthen its research and development in encapsulated cell therapies, specifically targeting Type 1 diabetes with its lead candidate, SIG-002, bolstering its position in the diabetes treatment market. Sigilon Therapeutics is a US-based biotechnology company focused on developing innovative cell therapies.
Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.
North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cell therapy market includes revenues earned by entities by enhancing the growth of new healthy skin tissue and enhancing collagen production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cell Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Technique: Stem Cell Therapy; Cell Vaccine; Adoptive Cell Transfer (ACT); Fibroblast Cell Therapy; Chondrocyte Cell Therapy
2) By Therapy Type: Allogeneic Therapies; Autologous Therapies
3) By Application: Oncology; Cardiovascular Disease (CVD); Orthopedic; Wound Healing; Other Applications
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Personalized Cell Therapy Development
4.2.2 Allogeneic Therapy Advancements
4.2.3 Improved Cell Storage & Transportation
4.2.4 Regulatory & Compliance Innovations
4.2.5 Emerging Clinical Applications
5. Cell Therapy Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialty Clinics
5.3 Research Institutes
5.4 Pharmaceutical & Biotech Companies
5.5 Regenerative Medicine Centers
6. Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Cell Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Cell Therapy Market Size, Comparisons And Growth Rate Analysis
7.3. Global Cell Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Cell Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Cell Therapy Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Cell Therapy Market Segmentation
9.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Cell Therapy Market, Sub-Segmentation Of Adoptive Cell Transfer (ACT), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Cell Therapy Market Regional And Country Analysis
10.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Cell Therapy Market
11.1. Asia-Pacific Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Cell Therapy Market
12.1. China Cell Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Cell Therapy Market
13.1. India Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Cell Therapy Market
14.1. Japan Cell Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Cell Therapy Market
15.1. Australia Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Cell Therapy Market
16.1. Indonesia Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Cell Therapy Market
17.1. South Korea Cell Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Cell Therapy Market
18.1. Taiwan Cell Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Cell Therapy Market
19.1. South East Asia Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Cell Therapy Market
20.1. Western Europe Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Cell Therapy Market
21.1. UK Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Cell Therapy Market
22.1. Germany Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Cell Therapy Market
23.1. France Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Cell Therapy Market
24.1. Italy Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Cell Therapy Market
25.1. Spain Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Cell Therapy Market
26.1. Eastern Europe Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Cell Therapy Market
27.1. Russia Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Cell Therapy Market
28.1. North America Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Cell Therapy Market
29.1. USA Cell Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Cell Therapy Market
30.1. Canada Cell Therapy Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Cell Therapy Market
31.1. South America Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Cell Therapy Market
32.1. Brazil Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Cell Therapy Market
33.1. Middle East Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Cell Therapy Market
34.1. Africa Cell Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Cell Therapy Market, Segmentation By Technique, Segmentation By Therapy Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Cell Therapy Market Regulatory and Investment Landscape
36. Cell Therapy Market Competitive Landscape And Company Profiles
36.1. Cell Therapy Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Cell Therapy Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Cell Therapy Market Company Profiles
36.3.1. Stempeutics Research Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Osiris Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Vericel Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.4. AlloSource Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Anterogen Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Cell Therapy Market Other Major And Innovative Companies
